The 56 references in paper O. Voronina L., M. Kunda S., N. Ryzhova N., E. Aksenova I., A. Semenov N., A. Lazareva V., S. Semykin Yu., E. Amelina L., O. Simonova I., S. Krasovskiy A., V. Lunin G., A. Baranov A., A. Chuchalin G., A. Gintsburg L., О. Воронина Л., М. Кунда С., Н. Рыжова Н., Е. Аксенова И., А. Семенов Н., А. Лазарева В., С. Семыкин Ю., Е. Амелина Л., О. Симонова И., С. Красовский А., В. Лунин Г., А. Баранов А., А. Чучалин Г., А. Гинцбург Л. (2015) “Разнообразие и опасность Achromobacter spp., поражающих дыхательные пути больных муковисцидозом // Diversity and hazard of respiratory infection of Achromobacter spp. in cystic fibrosis patients” / spz:neicon:pulmonology:y:2015:i:4:p:389-402

1
Woolhouse M.E. Population biology of emerging and re\n emerging pathogens. Trends Microbiol. 2002; 10 (10, Suppl.): S3–S7.
(check this in PDF content)
2
Mahenthiralingam E. Emerging cystic fibrosis pathogens and the microbiome.Paediatr. Respir. Rev.2014; 15 (Suppl. 1): 13–15. DOI: 10.1016/j.prrv.2014.04.006.
(check this in PDF content)
3
Yabuuchi E., Ohyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn. J. Microbiol. 1971; 15:
(check this in PDF content)
4
7–481. 4. Yabuuchi E., Yano I. Achromobacter gen. nov. and Achromobacter xylosoxidans (ex Yabuuchi and Ohyama 1971) norn. rev. Int. J. Syst. Bacteriol.1981; 31 (4): 477–478.
(check this in PDF content)
5
Kersters K., De Ley J. Genus Alcaligenes Castellani and Chalmers. 1919; 936': 365. In: Krieg N.R., Holt V., eds. Bergey's manual of systematic bacteriology. Baltimore / London: Williams & Wilkins Co; 1984. Vol. 1.
(check this in PDF content)
6
Davis D.H., Doudoroff M., Stanier R.Y., Mandel M. Proposal to reject the genus Hydrogenomonas. Taxonomic implications.Int. J. Syst. Bacteriol. 1969; 19: 375–390.
(check this in PDF content)
7
Aragno M., Schlegel H.G. Alcaligenes ruhlandii (Packer and Vishniac) comb. nov., a peritrichous hydrogen bacteri\n um previously assigned to Pseudomonas. Int. J. Syst. Bacteriol.1977; 27: 279–281.
(check this in PDF content)
8
Yabuuchi E., Kawamura Y., Kosako Y., Ezaki T. Emen\n dation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol. Immunol.1998; 42 (6): 429–438.
(check this in PDF content)
9
Gomila M., Tvrzova L., Teshim A. et al. Achromobacter marplatensis sp nov., isolated from a pentachlorophenol\n contaminated soil. Int. J. Syst. Evol. Microbiol. 2011; 61: 2231–2237.
(check this in PDF content)
10
Vandamme P., Moore E.R., Cnockaert M. et al. Clas\n sification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifa\n ciens sp. nov., Achromobacter anxifer sp. nov. and Achro\n mobacter dolens sp. nov., respectively. Syst. Appl. Microbiol. 2013; 36 (7): 474–482. DOI: 10.1016/j.syapm. 2013.06.005.
(check this in PDF content)
11
Vandamme P., Moore E.R., Cnockaert M. et al. Achromobacter animicus sp. nov., Achromobacter muci\n colens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples. Syst. Appl. Microbiol. 2013; 36: 1–10. DOI: 10.1016/j.syapm.2012.10.003.
(check this in PDF content)
12
List of Prokaryotic names with Standing in Nomenclature. Site founded by: Euzéby J.P., http:// www.bacterio.net/achromobacter.html
(check this in PDF content)
13
Peltroche\nLlacsahuanga H., Haase G., Kentrup H. Persis\n tent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis [letter]. Eur. J. Clin. Microbiol. Infect. Dis.1998; 17: 132–134.
(check this in PDF content)
14
Klinger J.D., Thomassen M.J. Occurrence and antimicro\n bial susceptibility of gram\nnegative nonfermentative bacilli in cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 1985; 3: 149–158. DOI:10.1016/0732\n8893(85)90025\n2.
(check this in PDF content)
15
Patient Registry. Annual Data Report to the Center Direc\n tors. 2013.Cystic Fibrosis Foundation.Bethesda, Maryland. 2013. www.cff.org
(check this in PDF content)
16
Dunne W.M. Jr, Maisch S. Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive\nelement\n sequence polymerase chain reaction. Clin. Infect. Dis. 1995; 20: 836–841.
(check this in PDF content)
17
Krzewinski J.W., Nguyen C.D., Foster J.M., Burns J.L. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achro\n mobacter (Alcaligenes) xylosoxidans from patients with cys\n tic fibrosis.J. Clin. Microbiol.2001; 39 (10): 3597–3602.
(check this in PDF content)
18
Spilker T., Vandamme P., Lipuma J.J. A multilocus sequ\n ence typing scheme implies population structure and reveals several putative novel achromobacter species. J. Clin. Microbiol. 2012; 50: 3010–3015.
(check this in PDF content)
19
Spilker T., Vandamme P., Lipuma J.J. Identification and distribution of Achromobacter species in cystic fibrosis. J. Cyst. Fibros.2013; 12 (3): 298–301. DOI: 10.1016/j.jcf.
(check this in PDF content)
20
2.10.002. 20. The Main Site PubMLST of the Faculty of Zoology. Great Britain, Oxford: Oxford of University.http:// pubmlst.org/
(check this in PDF content)
21
Zhang Z., Fan X., Gao X., Zhang X.H. Achromobacter sediminum sp. nov., isolated from deep subseafloor sedi\n ment of South Pacific Gyre. Int. J. Syst. Evol. Microbiol. 2014; 64 (Pt 7): 2244–2249. DOI: 10.1099/ijs.0.062265\n0.
(check this in PDF content)
22
Tan K., Conway S.P., Brownlee K.G. et al. Alcaligenes infec\n tion in cystic fibrosis. Pediatr. Pulmonol.2002; 34 (2): 101–104.
(check this in PDF content)
23
Registre français de la mucoviscidose – Bilan des données. 2013. http:// www.vaincrelamuco.org/sites/default/files/registre-2013.pdf
(check this in PDF content)
24
Vu\nThien H., Moissenet D., Valcin M. et al. Molecular epi\n demiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibro\n sis center. Eur. J. Clin. Microbiol. Infect. Dis. 1996; 15 (11): 876–879.
(check this in PDF content)
25
Amoureux L., Bador J., Siebor E. et al. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibro\n sis patients in Dijon, Burgundy: first French data.J. Cyst. Fibros. 2013; 12: 170–176.
(check this in PDF content)
26
Magni A., Trancassini M., Varesi P. et al. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with rele\n vant clinical features [corrected] of cystic fibrosis patients. J. Clin. Microbiol.2010; 48 (4):1035–1039. DOI: 10.1128/ JCM.02060\n09.
(check this in PDF content)
27
Trancassini M., Iebba V., CiteràN. et al. Outbreak of Achro\n mobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. Front. Microbiol. 2014; 5: 138. DOI: 10.3389/fmicb.2014.00138. eCollection 2014.
(check this in PDF content)
28
Lambiase A., Catania M.R., Del P.M. et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 2011; 30 (8): 973–980.
(check this in PDF content)
29
Wang M., Ridderberg W., Hansen C.R. et al. Early treat\n ment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. J. Cyst. Fibros. 2013; 12: 638–643. DOI: 10.1016/j.jcf.2013.04.013.
(check this in PDF content)
30
Steinkamp G., Wiedemann B., Rietschel E. et al. Prospec\n tive evaluation of emerging bacteria in cystic fibrosis. J. Cyst. Fibros. 2005; 4 (1): 41–48.
(check this in PDF content)
31
Barrado L., Brañas P., Orellana M.Á. et al. Molecular characterization of Achromobacter isolates from cystic fibrosis and non\ncystic fibrosis patients in Madrid, Spain. J. Clin. Microbiol. 2013; 51: 1927–1930. DOI: 10.1128/JCM. 00494\n13.
(check this in PDF content)
32
Kanellopoulou M., Pournaras S., Iglezos H. et al. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone.Eur. J. Clin. Microbiol. Infect. Dis. 2004; 23 (4): 336–339.
(check this in PDF content)
33
Baets F., Schelstraete P., van Daele S. et al. Achromo\n bacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros.2007; 6(1): 75–78.
(check this in PDF content)
34
Traglia G., Papalia M., Almuzara M. et al. Presence of OXA\ntype enzymes in Achromobacter insuavis and A. dolens. Curr. Microbiol. 2014; 69 (4): 501–506. DOI: 10.1007/s00284\n014\n0611\ny.
(check this in PDF content)
35
Pereira R.H., Carvalho\nAssef A.P., Albano R.M. et al. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients. J. Clin. Microbiol.2011; 49 (10): 3649–3651. DOI: 10.1128/JCM.05283\n11.
(check this in PDF content)
36
Dupont C., Michon A.L., Jumas\nBilak E. et al. Intrapatient diversity of Achromobacter spp. involved in chronic colo\n nization of Cystic Fibrosis airways. Infect. Genet. Evol. 2015; 32: 214–223. doi: 10.1016/j.meegid.2015.03.012
(check this in PDF content)
37
Papalia M., Almuzara M., Cejas D. et al. OXA\n258 from Achromobacter ruhlandii: a species\nspecific marker. J. Clin. Microbiol.2013; 51 (5): 1602–1605. DOI: 10.1128/JCM. 03043\n12.
(check this in PDF content)
38
Ridderberg W., Bendstrup K.E., Olesen H.V. et al. Marked increase in incidence of Achromobacter xylosoxidans infec\n tions caused by sporadic acquisition from the environment. J. Cyst. Fibros. 2011; 10: 466–469.
(check this in PDF content)
39
Ridderberg W., Wang M., Nørskov\nLauritsen N. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.J. Clin. Microbiol. 2012; 50 (8): 2688–2894. DOI: 10.1128/JCM.00728\n12.
(check this in PDF content)
40
Green H., Jones A.M. The microbiome and emerging pathogens in cystic fibrosis and non\ncystic fibrosis bronchi\n ectasis. Semin. Respir. Crit. Care Med.2015; 36 (2): 225–235. DOI: 10.1055/s\n0035\n1546752.
(check this in PDF content)
41
Lobo L.J., Tulu Z., Aris R.M., Noone P.G. Pan\nresistant Achromobacter xylosoxidans and Stenotrophomonas mal\n tophilia infection in cystic fibrosis does not reduce survival after lung transplantation. Transplantation. 2015, Apr. 8. [Epub ahead of print].
(check this in PDF content)
42
Lévesque R., Letarte R., Pechère J.C. Comparative study of the beta\nlactamase activity found in Achromobacter.Can. J. Microbiol. 1983; 29: 819–826.
(check this in PDF content)
43
Doi Y., Poirel L., Paterson D.L., Nordmann P. Characteri\n zation of a naturally occurring class D beta\nlactamase from Achromobacter xylosoxidans. Antimicrob. Agents. Chemother.2008; 52 (6): 1952–1956.
(check this in PDF content)
44
Воронина О.Л., Чернуха М.Ю., Шагинян И.А. и др. Характеристика генотипов штаммов Burkholderia cepa\n cia complex, выделенных от больных в стационарах Российской Федерации. Молекулярная генетика, микробиология и вирусология.2013; 2: 20–30.
(check this in PDF content)
45
Воронина О.Л., Кунда М.С., Аксенова Е.И. и др. Экспресс диагностика микроорганизмов, поражающих дыхательные пути больных муковисцидозом. Клиническая лабораторная диагностика. 2013; 11: 53–58.
(check this in PDF content)
46
Voronina O.L., Kunda M.S., Ryzhova N.N. et al. The vari\n ability of the order Burkholderiales representatives in the Healthcare Units. BioMed. Res. Int.2015; 2015: 680210. DOI:10.1155/2015/68021.
(check this in PDF content)
47
Методические указания МУК 4.2.1890\n04 "Определе\n ние чувствительности микроорганизмов к антибакте\n риальным препаратам" (утв. Главным государственным санитарным врачом РФ 04.03.04).
(check this in PDF content)
48
The Main Site EUCAST. http:// www.eucast.org/
(check this in PDF content)
49
Delgado S., Arroyo R., Jiménez E. et al. Staphylococcus epi\n dermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics. BMC Microbiol.2009; 9: 82. DOI: 10.1186/1471\n 2180\n9\n82.
(check this in PDF content)
50
Spilker T., Baldwin A., Bumford A. et al. Expanded multilo\n cus sequence typing for Burkholderia species. J. Clin. Microbiol.2009; 47 (8): 2607–2610. DOI: 10.1128/JCM. 00770\n09.
(check this in PDF content)
51
Turton J.F., Mustafa N., Shah J. et al. Identification of Achromobacter xylosoxidans by detection of the bla(OXA\n 114\nlike) gene intrinsic in this species. Diagn. Microbiol. Infect. Dis. 2011; 70 (3): 408–411. DOI: 10.1016/j.diagmi\n crobio.2011.02.007.
(check this in PDF content)
52
The Main Site CBMAR: Comprehensive Beta\nlactamase Molecular Annotation Resource, University of Delhi South Campus, New Delhi, India. http://14.139.227.92/mkumar/ lactamasedb/
(check this in PDF content)
53
The Main Site EMBL\nEBI, European Bioinformatics Institute.http:// www.ebi.ac.uk
(check this in PDF content)
54
The Main Site PubMLST of the Faculty of Zoology, Oxford University, Great Britain, Achromobacter MLST Databases. http:// pubmlst.org/achromobacter/
(check this in PDF content)
55
Amoureux L., Bador J., Fardeheb S. et al. Detection of Achromobacter xylosoxidans in hospital, domestic, and out\n door environmental samples and comparison with human clinical isolates. Appl. Environ. Microbiol.2013; 79 (23): 7142–7149. DOI: 10.1128/AEM.02293\n13.
(check this in PDF content)
56
Воронина О.Л., Кунда М.С., Рыжова Н.Н. и др. Законо\n мерности селекции полигостальных убиквитарных микроорганизмов на примере представителей трех так\n сонов. Молекулярная биология. 2015; 49 (3): 430–441, DOI: 10.7868/S0026898415030179.
(check this in PDF content)